Reducing the acute pain and the need to narcotic pain relievers after cesarean surgery
- Conditions
- cesarean surgery.Maternal care for known or suspected malpresentation of fetus
- Registration Number
- IRCT2013022512593N1
- Lead Sponsor
- Ahvaz Jundishapur University of Medical Sciences (AJUMS)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 99
Being in ASA class 1 or 2; Being in ages between 18-35; Being first or second pregnancy.
Exclusion criteria: Having any known allergies and sensitivities, banned from narcotic drugs, paracetamol, and NSAIDs; Hepatic Dysfunction (transaminaze twice than upper limit of normal level); Kidney dysfunction (plasma creatinine higher than 2.5 mg/dl); Smoking or having any previous pulmonary disease; Drug, narcotic, and alcohol abuse; Subjects with the history of depression or chronic anxiety;Subjects experienced the side effects of spinal anesthesia: back pain, radicular pain, paresthesia and hypoesthesia, PDPH; Spinal contraindication; Contraindications for the Use of Spinal Anesthesia (Patient decline, infection in the spot for entering the needle, high intracranial pressure, bleeding susceptibility).
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patient reported pain level. Timepoint: 1, 4, 12, and 24 hours after surgery. Method of measurement: Visual Analog Scale for Pain (VAS Pain).
- Secondary Outcome Measures
Name Time Method Intravenous Morphine. Timepoint: in periods of 0-4; 4-12; and 12-24 hours after surgey. Method of measurement: intravenous morphine dose (mg/kg).